|
Cannabis Campaigners' Guide News Database result:
|
|
World Marijuana Health News in Brief
BBS News: Marijuana Health News
Monday 29 May 2006 IACM via BBSNews 2006-05-29 -- The city council of the Swiss capital Bern decided to start a pilot project on the controlled sale of cannabis, although the federal government and the canton oppose it. It is intended that in the project cannabis will be allowed to be sold if certain rules are followed, such as prohibition of advertisement, no sale to minors and maximum amount of sale per day. A measure in support of a controlled sale of cannabis failed last year in the Swiss Parliament. Source: 20min.ch of 23 May 2006 Italy: Law changes On 9 May a law introduced by the old government that increased sanctions for the possession of small amounts of drugs went into effect. However, four new bills proposed after the election of the new government in May would depenalize the possession of cannabis and improve the possibilities of therapeutic uses. Sources: dire of 5 and 8 May 2006 Science: Liver fibrosis French researchers reported that treatment with a CB1 receptor antagonist decreased the wound-healing response to acute liver injury in mice and inhibited progression of fibrosis in three models of chronic liver injury. They concluded that "our study shows that CB1 receptor antagonists hold promise for the treatment of liver fibrosis." Source: Teixeira-Clerc F, et al. Nat Med. 2006 May 21; [Electronic publication ahead of print]. Science: Depression Canadian researchers found that the cannabinoid system is involved in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced increase of corticosterone levels in mice. Three-week administration of the tricyclic antidepressant desipramine resulted in a significant increase in the density of CB1 receptors in certain brain areas (hippocampus and hypothalamus) without significantly altering endocannabinoid levels. The reduction of stress-induced corticosterone secretion by the antidepressant was blocked by a CB1 receptor antagonist. Source: Hill MN, et al. Neuropsychopharmacology. 2006 May 10; [Electronic Publication ahead of print]. ONE YEAR AGO: * Science: THC helps to reduce delayed nausea following cancer chemotherapy * UK/Science: Three-year study to look into therapeutic effects of THC in multiple sclerosis TWO YEARS AGO: * USA: Vermont is the tenth state to allow the medical use of cannabis * Science: No strong evidence that use of cannabis causes psychological problems, results of a new study show For previous bulletins see the archives of the International Association for Cannabis as Medicine (IACM). http://www.cannabis-med.org/ http://bbsnews.net/article.php/20060529231632662
After you have finished reading this article you can click here to go back.
|
This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!